| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | Director | Common Stock | 41,046 | $43,234 | $1.05 | 21 May 2023 | Direct |
| LEXICON PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 12,658 | 28 Apr 2023 | Direct | ||
| LEXICON PHARMACEUTICALS, INC. | Director | Restricted Stock Units | 0 | 21 May 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LXRX | LEXICON PHARMACEUTICALS, INC. | 21 May 2023 | 2 | $0 | 4 | Director | 22 May 2023, 16:05 |
| LXRX | LEXICON PHARMACEUTICALS, INC. | 28 Apr 2023 | 2 | $0 | 4 | Director | 28 Apr 2023, 16:25 |
| LXRX | LEXICON PHARMACEUTICALS, INC. | 21 May 2022 | 2 | $0 | 4 | Director | 23 May 2022, 16:16 |
| LXRX | LEXICON PHARMACEUTICALS, INC. | 30 Apr 2022 | 2 | $0 | 4 | Director | 02 May 2022, 16:16 |